ÂÜÀòÂÒÂ×

Silvina Garcia Rubio is an accomplished professional in the biopharmaceutical industry, currently serving as Vice President of CMC at Formation Bio since May 2023. Prior to this role, Silvina held the position of Vice President of CMC at Crinetics Pharmaceuticals from May 2020 to May 2023 and has extensive experience in leadership positions including Vice President of Process Chemistry and Program Management at Bridge Medicines, Senior Director of Technical Operations at Veloxis Pharmaceuticals, and Executive Director of Technical Affairs at Helsinn Therapeutics (U.S.), Inc. Silvina's earlier roles include Director of CMC Development at Helsinn Therapeutics US, Inc., and various positions at Sapphire Therapeutics, AMRI, and Cornell University. Silvina's educational background includes studies at Universitat de Barcelona and Universidad de la República.